Advertisement
Advertisement

AMPH

AMPH logo

Amphastar Pharmaceuticals, Inc.

16.87
USD
Sponsored
-0.43
-2.49%
May 15, 15:59 UTC -4
Closed
exchange

After-Market

17.41

+0.54
+3.23%

Amphastar Pharmaceuticals, Inc. Profile

About

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

Info & Links

CEO

Jack Yongfeng Zhang

Headquarters

11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730, UNITED STATES

Industry

Medical Generic Drugs

Sector

Medical

Website

www.amphastar.com

Auditor

Ernst & Young LLP

Share holders

115

Employees

1,976

Amphastar Pharmaceuticals, Inc. Statistics

Valuation Measures

Market Capitalization2

767.88M

Enterprise Value

1.21B

Enterprise Value/EBITDA(ttm)

6.03

Price to Earnings Ratio(ttm)

7.45

Price to Sales(ttm)

1.32

Price to Book(mrq)

1.22

Price to Cash(ytd)

4.91

Profitability

Gross Margin(ttm)

49.45%

Operating Margin(ttm)

18.77%

Profit Margin(ttm)

13.75%

Return on Equity(ttm)

17.58%

Return on Invested Capital(ttm)

7.14%

Return on Assets(ttm)

8.27%

Income Statement

Revenue(ttm)

719.89M

Revenue Per Share(ttm)

15.87

Gross Profit(ttm)

356.06M

EBITDA(ttm)3

200.45M

Net Income Available to Common(ttm)

98.09M

Diluted EPS(ttm)

2.03

Share Statistics

Beta (5Y Monthly)

0.92

52-Week Change

-27.60%

S&P 500 52-Week Change

24.34%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

45.37M

Dividend Yield

0.00%

Float4

32.89M

% Held by Insiders

27.50%

% Held by Institutions

65.09%

Balance Sheet

Total Cash(mrq)

285.25M

Total Cash Per Share(mrq)

6.29

Total Debt(mrq)

610.39M

Total Debt/Equity(mrq)

77.38%

Current Ratio(mrq)

4.02%

Quick Ratio(mrq)

2.90%

Book Value Per Share(mrq)

17.28

Cash Flow

Operating Cash Flow Per Share(ytd)

3.24

Free Cash Flow(ytd)

121.23M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement